| scholarly article | Q13442814 |
| P50 | author | Scott H Kaufmann | Q40592168 |
| Richard Weinshilboum | Q52447985 | ||
| Bingshu E. Chen | Q56027887 | ||
| Krishna R Kalari | Q57034862 | ||
| Erin E Carlson | Q57034978 | ||
| Peter A. Fasching | Q64005064 | ||
| Tufia C Haddad | Q88683050 | ||
| Matthew J Ellis | Q88724457 | ||
| Junmei Cairns | Q89093061 | ||
| Liewei Wang | Q89121645 | ||
| James N Ingle | Q89668737 | ||
| Matthew Cuellar | Q89687489 | ||
| Cristina Correia | Q89881418 | ||
| Poulami Barman | Q90864335 | ||
| Matthew P Goetz | Q95259846 | ||
| Vera J Suman | Q96186734 | ||
| Tanya L. Hoskin | Q112864195 | ||
| Barbara A Goodnature | Q116795072 | ||
| P2093 | author name string | Paul E Goss | |
| Michael A Walters | |||
| Zeruesenay Desta | |||
| Ravinder J Singh | |||
| Lois E Shepherd | |||
| Bernhard Volz | |||
| P2860 | cites work | Isolation of a full-length cDNA insert encoding human aromatase system cytochrome P-450 and its expression in nonsteroidogenic cells | Q24293133 |
| Estrogen receptor alpha: impact of ligands on intracellular shuttling and turnover rate in breast cancer cells | Q28297182 | ||
| Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): explanation and elaboration | Q30514241 | ||
| Anastrozole versus megestrol acetate in the treatment of postmenopausal women with advanced breast carcinoma: results of a survival update based on a combined analysis of data from two mature phase III trials. Arimidex Study Group | Q32020808 | ||
| Liquid chromatography-tandem mass spectrometry assay for simultaneous measurement of estradiol and estrone in human plasma | Q33430674 | ||
| Molecular cloning of a novel mouse gene with predominant muscle and neural expression | Q34462845 | ||
| Conversion of abiraterone to D4A drives anti-tumour activity in prostate cancer | Q34478734 | ||
| Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials | Q34486930 | ||
| Estrogens and their precursors in postmenopausal women with early breast cancer receiving anastrozole | Q35118969 | ||
| Aromatase inhibitors in breast cancer | Q35152297 | ||
| Influence of anastrozole (Arimidex), a selective, non-steroidal aromatase inhibitor, on in vivo aromatisation and plasma oestrogen levels in postmenopausal women with breast cancer | Q36138879 | ||
| Aromatase, breast cancer and obesity: a complex interaction | Q36191587 | ||
| Obesity and risk of recurrence or death after adjuvant endocrine therapy with letrozole or tamoxifen in the breast international group 1-98 trial | Q36368902 | ||
| Exemestane versus anastrozole in postmenopausal women with early breast cancer: NCIC CTG MA.27--a randomized controlled phase III trial | Q36729512 | ||
| Overview of adjuvant trials of aromatase inhibitors in early breast cancer | Q37850520 | ||
| Estradiol assays--The path ahead | Q38243494 | ||
| Contribution of Bcl-2 phosphorylation to Bak binding and drug resistance. | Q41906775 | ||
| Effect of body mass index on recurrences in tamoxifen and anastrozole treated women: an exploratory analysis from the ATAC trial | Q43023364 | ||
| Influence of letrozole and anastrozole on total body aromatization and plasma estrogen levels in postmenopausal breast cancer patients evaluated in a randomized, cross-over study | Q43872782 | ||
| Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women | Q44472863 | ||
| Letrozole is superior to anastrozole in suppressing breast cancer tissue and plasma estrogen levels | Q44893183 | ||
| Comparative Efficacy and Safety of Adjuvant Letrozole Versus Anastrozole in Postmenopausal Patients With Hormone Receptor-Positive, Node-Positive Early Breast Cancer: Final Results of the Randomized Phase III Femara Versus Anastrozole Clinical Evalu | Q47987903 | ||
| Protein-Observed Fluorine NMR Is a Complementary Ligand Discovery Method to 1H CPMG Ligand-Observed NMR. | Q51508253 | ||
| Classification accuracy and cut point selection. | Q53670020 | ||
| Randomized Trial of Aromatase Inhibitors, Growth Hormone, or Combination in Pubertal Boys with Idiopathic, Short Stature. | Q55137873 | ||
| Biological aromatization of steroids | Q78556534 | ||
| Why match? Investigating matched case-control study designs with causal effect estimation | Q83193452 | ||
| P921 | main subject | anastrozole | Q419143 |
| P577 | publication date | 2020-02-25 | |
| P1433 | published in | Clinical Cancer Research | Q332253 |
| P1476 | title | Anastrozole has an association between degree of estrogen suppression and outcomes in early breast cancer and is a ligand for estrogen receptor α |
Search more.